Louisiana House Bill HR37

Louisiana 2020 Regular Session

• Introduced: 5/15/20
• Refer: 5/18/20
• Report Pass: 5/20/20
• Passed: 6/1/20

Caption

Urges the Conservative Care Program as a pilot program among healthcare providers and health insurers to address opioid misuse

Impact

If implemented successfully, HR37 would transform the approach to treating acute low back pain in Louisiana. By shifting focus from opioid prescriptions to conservative care, the bill proposes a substantial change in the healthcare landscape, particularly aimed at reducing the number of opioid prescriptions issued. Results from this pilot program would be critical in shaping future policies and practice guidelines, potentially easing the burden of opioid addiction on both individuals and the healthcare system as a whole.

Summary

House Resolution 37 (HR37) aims to address the ongoing opioid crisis by urging the establishment of a pilot program that encourages patients with acute low back pain to seek conservative care instead of relying on opioid prescriptions. The resolution calls on the Louisiana Conservative Care Group and health insurers to promote the use of treatment options such as chiropractic care, physical therapy, and other non-invasive methods. The intent is to mitigate the risks of addiction and misuse associated with opioid medications by educating patients on alternative treatment paths.

Sentiment

The sentiment surrounding HR37 appears to be largely supportive, particularly among those concerned about the opioid epidemic. Advocates for the resolution commend its proactive approach in offering patients viable alternatives to opioids, enhancing both patient care and safety. However, there may be concerns from medical professionals who are apprehensive about the reliance on non-traditional treatment methods without clear regulatory standards and acknowledgment of the potential need for medication in severe cases.

Contention

Notable points of contention focus on the effectiveness and acceptance of conservative care approaches as alternatives to traditional pain management strategies. Critics may argue that while the pilot program promotes healthy practices, there is skepticism about the adequacy of these treatments for all patients, particularly those with severe pain or underlying conditions that necessitate opioid use. Additionally, discussions regarding insurance coverage and incentivization mechanisms for patients to participate in the pilot program may spark debates around healthcare accessibility and equality.